Browse > Article
http://dx.doi.org/10.3340/jkns.2021.0098

The Effect of Genetically Modified Lactobacillus plantarum Carrying Bone Morphogenetic Protein 2 Gene on an Ovariectomized Rat  

Jin, Eun-Sun (Department of Internal Medicine, College of Medicine, Kyung Hee University)
Kim, Ji Yeon (Laboratory of Stem Cell Therapy, Asan Medical Center, College of Medicine, University of Ulsan)
Yang, Jung-Mo (Department of Biotechnology, Korea National University of Transportation)
Kim, Jun-Sub (Department of Biotechnology, Korea National University of Transportation)
Min, JoongKee (Laboratory of Stem Cell Therapy, Asan Medical Center, College of Medicine, University of Ulsan)
Jeon, Sang Ryong (Laboratory of Stem Cell Therapy, Asan Medical Center, College of Medicine, University of Ulsan)
Choi, Kyoung Hyo (Laboratory of Stem Cell Therapy, Asan Medical Center, College of Medicine, University of Ulsan)
Moon, Gi-Seong (Department of Biotechnology, Korea National University of Transportation)
Jeong, Je Hoon (Laboratory of Stem Cell Therapy, Asan Medical Center, College of Medicine, University of Ulsan)
Publication Information
Journal of Korean Neurosurgical Society / v.65, no.2, 2022 , pp. 204-214 More about this Journal
Abstract
Objective : Osteoporosis result from age-related decline in the number of osteoblast progenitors in the bone marrow. Probiotics have beneficial effects on the host, when administered in appropriate amounts. This study investigated the effects of probiotics expressing specific genes, especially the effects of genetically modified bone morphogenetic protein (BMP)-2-expressing Lactobacillus plantarum CJNU 3003 (LP) on ovariectomized rats. Methods : Twenty-eight female Wistar rats (250-300 g, 12 weeks old) were divided into four groups : the sham (control), the ovariectomy (OVX)-induced osteoporosis group (OVX), the OVX and LP (OVX/LP), OVX and genetically modified BMP-2-expressing LP (OVX/LP with BMP) groups. The three groups underwent bilateral OVX and two of these groups were administered two different types of LP via oral gavage daily. At 16 weeks post-OVX, blood was collected from the heart and the bilateral tibiae were extracted and were scanned by ex-vivo micro-computed tomography and stained with hematoxylin-and-eosin (H&E) and Masson's trichrome stain for pathological assessment. The serum levels of osteocalcin (OC), rat C-telopeptide of type I collagen (CTX-I), BMP-2, and receptor activator of nuclear factor-ĸB ligand (RANKL) were measured. Results : The 3D-micro-computed tomography images showed that the trabecular structure in the OVX/LP with BMP group was maintained compared with OVX and OVX/LP groups. No significant differences were detected in trabecular thickness (Tb.Th) between control and OVX/LP with BMP groups (p>0.05). Furthermore, a tendency toward increased BMD, trabecular bone volume, Tb.Th, and trabecular number and decreased trabecular separation was found in rats in the OVX/LP with BMP groups when compared with the OVX and OVX/LP groups (p>0.05). The H&E and Masson's trichrome stained sections showed a thicker trabecular bone in the OVX/LP with BMP group compared with the OVX and OVX/LP groups. There was no difference in serum levels of OC, CTX and RANKL control and OVX/LP with BMP groups (p>0.05). In contrast, significant differences were found in OC and CTX-1 levels between the OVX and OVX/LP with BMP groups (p<0.05). Conclusion : Our results showed that the expression of genetically modified BMP-2 showed inhibition effect for bone loss in a rat model of osteoporosis.
Keywords
Probiotics; Osteoporosis; Models, animal; Gene editing; Bone morphogenetic protein 2;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Chilton SN, Burton JP, Reid G : Inclusion of fermented foods in food guides around the world. Nutrients 7 : 390-404, 2015   DOI
2 de Moreno de LeBlanc A, Del Carmen S, Chatel JM, Miyoshi A, Azevedo V, Langella P, et al. : Current review of genetically modified lactic acid bacteria for the prevention and treatment of colitis using murine models. Gastroenterol Res Pract 2015 : 146972, 2015   DOI
3 de Vrese M, Schrezenmeir J : Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111 : 1-66, 2008
4 Friedenstein AJ : Precursor cells of mechanocytes. Int Rev Cytol 47 : 327-359, 1976   DOI
5 Howarth GS, Wang H : Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients 5 : 58-81, 2013   DOI
6 Jung UW, Choi SY, Pang EK, Kim CS, Choi SH, Cho KS : The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 77 : 765-772, 2006   DOI
7 Kailasapathy K, Chin J : Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78 : 80-88, 2000   DOI
8 Kanakaris NK, Petsatodis G, Tagil M, Giannoudis PV : Is there a role for bone morphogenetic proteins in osteoporotic fractures? Injury 40 Suppl 3 : S21-S26, 2009
9 Abdul-Majeed S, Mohamed N, Soelaiman IN : Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis. Evid Based Complement Alternat Med 2012 : 960742, 2012
10 Moon GS, Lee YD, Kim WJ : Screening of a novel lactobacilli replicon from plasmids of Lactobacillus reuteri KCTC 3678. Food Sci Biotechnol 17 : 438-441, 2008
11 Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, et al. : Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66 : 100-103, 2000   DOI
12 Sakata T, Kojima T, Fujieda M, Miyakozawa M, Takahashi M, Ushida K : Probiotic preparations dose-dependently increase net production rates of organic acids and decrease that of ammonia by pig cecal bacteria in batch culture. Dig Dis Sci 44 : 1485-1493, 1999   DOI
13 Astrand P, Ahlqvist J, Gunne J, Nilson H : Implant treatment of patients with edentulous jaws: a 20-year follow-up. Clin Implant Dent Relat Res 10 : 207-217, 2008
14 Eom JE, Moon SK, Moon GS : Heterologous production of pediocin PA-1 in Lactobacillus reuteri. J Microbiol Biotechnol 20 : 1215-1218, 2010   DOI
15 Ivaska KK, Hentunen TA, Vaaraniemi J, Ylipahkala H, Pettersson K, Vaananen HK : Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279 : 18361-18369, 2004   DOI
16 Christiansen C : Prevention and treatment of osteoporosis: a review of current modalities. Bone 13 Suppl 1 : S35-S39, 1992   DOI
17 Yamaguchi K, Masuhara K, Yamasaki S, Nakai T, Fuji T : Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty. Bone 33 : 144-149, 2003   DOI
18 Kalu DN : The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15 : 175-191, 1991   DOI
19 Kimoto-Nira H, Suzuki C, Kobayashi M, Sasaki K, Kurisaki J, Mizumachi K : Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice. Br J Nutr 98 : 1178-1186, 2007   DOI
20 McCabe LR, Irwin R, Schaefer L, Britton RA : Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol 228 : 1793-1798, 2013   DOI
21 Legrand E, Chappard D, Pascaretti C, Duquenne M, Krebs S, Rohmer V, et al. : Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res 15 : 13-19, 2000   DOI
22 Rubin CJ, Lindberg J, Fitzsimmons C, Savolainen P, Jensen P, Lundeberg J, et al. : Differential gene expression in femoral bone from red junglefowl and domestic chicken, differing for bone phenotypic traits. BMC Genomics 8 : 208, 2007   DOI
23 Khosla S, Westendorf JJ, Oursler MJ : Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118 : 421-428, 2008   DOI
24 LeBlanc JG, Aubry C, Cortes-Perez NG, de Moreno de LeBlanc A, Vergnolle N, Langella P, et al. : Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol Lett 344 : 1-9, 2013   DOI
25 Urist MR : Bone morphogenetic protein: the molecularization of skeletal system development. J Bone Miner Res 12 : 343-346, 1997   DOI
26 Parvaneh K, Ebrahimi M, Sabran MR, Karimi G, Hwei AN, Abdul-Majeed S, et al. : Probiotics (Bifidobacterium longum) increase bone mass density and upregulate sparc and BMP-2 genes in rats with bone loss resulting from ovariectomy. Biomed Res Int 2015 : 897639, 2015   DOI
27 Romero Barco CM, Manrique Arija S, Rodriguez Perez M : Biochemical markers in osteoporosis: usefulness in clinical practice. Reumatol Clin 8 : 149-152, 2012   DOI
28 Styrkarsdottir U, Cazier JB, Kong A, Rolfsson O, Larsen H, Bjarnadottir E, et al. : Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 1 : E69, 2003   DOI
29 Mutus R, Kocabagli N, Alp M, Acar N, Eren M, Gezen SS : The effect of dietary probiotic supplementation on tibial bone characteristics and strength in broilers. Poult Sci 85 : 1621-1625, 2006   DOI
30 Moon GS, Pyun YR, Park MS, Ji GE, Kim WJ : Secretion of recombinant pediocin PA-1 by Bifidobacterium longum, using the signal sequence for bifidobacterial alpha-amylase. Appl Environ Microbiol 71 : 5630- 5632, 2005   DOI
31 Shim KS, Kim T, Ha H, Lee KJ, Cho CW, Kim HS, et al. : Lactobacillus fermentation enhances the inhibitory effect of Hwangryun-haedok-tang in an ovariectomy-induced bone loss. BMC Complement Altern Med 13 : 106, 2013   DOI
32 Moslehi-Jenabian S, Pedersen LL, Jespersen L : Beneficial effects of probiotic and food borne yeasts on human health. Nutrients 2 : 449-473, 2010   DOI
33 Park SB, Lee YJ, Chung CK : Bone mineral density changes after ovariectomy in rats as an osteopenic model : stepwise description of double dorso-lateral approach. J Korean Neurosurg Soc 48 : 309-312, 2010   DOI
34 Parvaneh K, Jamaluddin R, Karimi G, Erfani R : Effect of probiotics supplementation on bone mineral content and bone mass density. ScientificWorldJournal 2014 : 595962, 2014
35 Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, et al. : New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37 : 105-118, 2003   DOI
36 Scholz-Ahrens KE, Schrezenmeir J : Inulin and oligofructose and mineral metabolism: the evidence from animal trials. J Nutr 137(11 Suppl) : 2513S-2523S, 2007   DOI
37 Szulc P, Delmas PD : Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int 19 : 1683-1704, 2008   DOI
38 Turner AS : Animal models of osteoporosis--necessity and limitations. Eur Cell Mater 1 : 66-81, 2001   DOI
39 Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, et al. : The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29 : 2520-2526, 2014   DOI
40 Vitetta L, Briskey D, Alford H, Hall S, Coulson S : Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology 22 : 135-154, 2014   DOI